Clopidogrel

Key facts

Invented name
Iscover
Active substance
clopidogrel
Therapeutic area
Cardiovascular diseases
Decision number
P/123/2008
PIP number
Clopidogrel
Pharmaceutical form(s)
  • Oral formulation
  • Film-coated tablet
Condition(s) / indication(s)
Thromboembolic events
Route(s) of administration
Oral use
Contact for public enquiries
Applicant: Bristol-Myers Squibb Pharma EEIG
E-mail: sylvie.gabriel@sanofi-aventis.com
Country: France
Phone: +33 153774152
Fax: +33 153774133
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating